 | • レポートコード：C-MOR-100142 • 出版社/出版日：Mordor Intelligence / 2019年9月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site License | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗コクシジウム剤の世界市場について調査・分析し、抗コクシジウム剤の世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。 |
Market Overview
The key factors propelling the growth of the market studied are increased the incidence of Coccidiosis in food-producing animals and companion animals. Along with this, advancements in veterinary healthcare is another factor that is fuelling Anticoccidial Drugs market across the world. For instance, in April 2019 Creative Diagnostics announced the launch of a series of innovative anticoccidial drug analysis products and services for its global clients. However, the use of alternative treatments such as vaccines and herbal remedies to treat Coccidiosis is likely to hamper the growth of Anticoccidial drugs market across the world.
Scope of the Report
Coccidiosis is one of the most frequent and prevalent parasitic diseases of domesticated animals and its symptoms include weight loss, mild intermittent to severe diarrhea, feces containing mucus or blood, dehydration, and decreased breeding. Coccidiosis is caused by single-celled parasites (protozoa) called Eimeria, which undergo a simple life cycle in the gut. Any drug used to combat the progression of coccidiosis in birds or animals, both food-producing and non-food producing, is termed as an anticoccidial.
Key Market Trends
Ionophore Anticoccidial segment dominates the Anticoccidial Drugs Market
A major breakthrough in the prevention of coccidiosis through feed medication occurred in 1972, with the launch of the first polyether ionophore anticoccidial, monensin. This type of anticoccidial agents has been commonly referred to as ionophores, a term derived from their general chemical structure. Ionophores are the fermentation products of Streptomyces and other fungi species, they are the most widely used drugs for coccidiosis prevention because of its broad-spectrum activity against the majority of pathogenic species of coccidian and lack of development of drug resistance. Each has a different mode of action and no significant resistance has been developed. These drugs are commonly added to the starter and grower feeds but not to the finisher or withdrawal feeds. When the same ionophore anticoccidial is added to the starter and grower feeds, this is popularly referred to as a straight program. In 2017, the US Food and Drug Administration reported that 82% of all domestic sales and distribution of non-medically important antimicrobials were from ionophores, amounting to 4,394,850 kg. As a result of the aforementioned factors, the ionophore anticoccidial segment is expected to experience healthy growth during the forecast period.
North America is the fastest-growing region for Anticoccidial Drugs Market
North America is the major market for anticoccidial drugs globally. North America anticoccidial drugs market is currently thriving with rapid growth. This success is mainly owing to the availability of multiple anticoccidial drugs, both chemicals, and polyether ionophores and by the prophylactic usage of anticoccidials in animal feed. Furthermore, factors such as awareness for the prevention of coccidiosis, safe animal food supply, and high investment in R&D in developing novel products are likely to propel the North America Anticoccidial Drugs market during the forecast period.
Competitive Landscape
Market players in global Anticoccidial Drugs are focusing on continuous product development and adopting growth strategies such as mergers, acquisitions, partnerships with other market players. Major Players include Bayer Animal Healthcare, Boehringer Ingelheim, Ceva Animal Health Inc., Elanco Animal Health, Merck, Merial, Virbac, Zoetis Animal Healthcare, and others.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Incidence of Coccidiosis globally
4.2.2 Advancements in the Veterinary healthcare
4.3 Market Restraints
4.3.1 Availability of Alternative Treatment Options in the Market
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Drug Type
5.1.1 Ionophore Anticoccidials
5.1.2 Chemical Derivative Anticoccidials
5.2 By Animal
5.2.1 Poultry
5.2.2 Swine
5.2.3 Fish
5.2.4 Cattle
5.2.5 Companion Animals
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Zoetis Animal Healthcare
6.1.2 Phibro Animal Health Corporation
6.1.3 Huvepharma
6.1.4 Elanco
6.1.5 Bayer AG
6.1.6 Ceva Animal Health Inc.
6.1.7 Impextraco NV
6.1.8 Virbac
6.1.9 Boehringer Ingelheim International GmbH
6.1.10 MSD Animal Health
6.1.11 Vetoquinol SA
7 MARKET OPPORTUNITIES AND FUTURE TRENDS